Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

P Hemachandra Reddy1

  • 1Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, 97006, USA. reddyh@ohsu.edu

Experimental Neurology
|April 11, 2009
PubMed

Insights

Amyloid precursor protein (APP) and amyloid beta (Abeta) accumulation damages brain cell mitochondria, disrupting neuron function in Alzheimer's disease (AD). This leads to mitochondrial dysfunction and impaired neuronal calcium regulation.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondria are crucial for neuronal energy production.
  • Accumulation of amyloid precursor protein (APP) and amyloid beta (Abeta) in brain mitochondria is increasingly implicated in neurodegenerative diseases.
  • Mitochondrial dysfunction is a key feature in Alzheimer's disease (AD) pathogenesis.

Purpose of the Study:

  • To explore the critical role of APP/Abeta in mitochondrial structural and functional damage within AD neurons.
  • To investigate the link between Abeta accumulation, altered intracellular calcium regulation, and impaired mitochondrial dynamics in AD.
  • To propose how APP overexpression and Abeta production contribute to mitochondrial abnormalities in AD.

Main Methods:

  • Analysis of gene expression in APP transgenic mice and postmortem AD brains.
  • Mitochondrial structural and functional studies in relation to APP/Abeta.
  • Investigation of intracellular calcium (Ca2+) levels and mitochondrial permeability transition pore opening.

Main Results:

  • Oligomeric Abeta induces intracellular Ca2+ overload, leading to mitochondrial permeability transition pore opening and structural damage.
  • APP/Abeta accumulation in mitochondrial membranes causes structural and functional deficits in neurons.
  • Evidence suggests APP overexpression and increased Abeta production lead to defective mitochondria, reduced trafficking, and altered mitochondrial dynamics in AD.

Conclusions:

  • APP/Abeta significantly contributes to mitochondrial damage and dysfunction in AD.
  • Impaired mitochondrial dynamics and altered calcium regulation are critical consequences of Abeta accumulation in AD neurons.
  • Targeting APP/Abeta interactions with mitochondria may offer therapeutic strategies for AD.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...